UK funds ‘long COVID’ research drive as restrictions easeThe UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to Share XUK funds ‘long COVID’ research drive as restrictions easehttps://pharmaphorum.com/news/uk-funds-long-covid-treatment-drive-as-restrictions-ease/
UK study raises hopes of long COVID test within monthsA diagnostic test to detect long COVID could be available within six to 12 months, following the discovery Share XUK study raises hopes of long COVID test within monthshttps://pharmaphorum.com/news/uk-study-raises-hopes-of-long-covid-test-within-months/
Pharma poised to cash in on ‘long COVID’ symptomsWhile there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue Share XPharma poised to cash in on ‘long COVID’ symptomshttps://pharmaphorum.com/news/big-pharma-could-cash-in-on-long/
PureTech begins trial of potential ‘Long COVID’ drug as cases mountAs the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after Share XPureTech begins trial of potential ‘Long COVID’ drug as cases mounthttps://pharmaphorum.com/news/puretech-begins-trial-of-potential-long-covid-drug-as-cases-mount/
